Tenax Therapeutics
TENX
11 hedge funds and large institutions have $57.2K invested in Tenax Therapeutics in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
87% more capital invested
Capital invested by funds: $30.5K → $57.2K (+$26.7K)
22% more funds holding
Funds holding: 9 → 11 (+2)
0.55% more ownership
Funds ownership: 0.41% → 0.96% (+0.55%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$39.1K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.5K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$407 |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$57 |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$4 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$8 |
| 2 |
TAM
Tucker Asset Management
Littleton,
Colorado
|
-$4 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Geode Capital Management
Boston,
Massachusetts
| $33.6K | +$39.1K | +11,041 | New |
|
2
Qube Research & Technologies (QRT)
London,
United Kingdom
| $13.4K | – | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| $4.52K | +$407 | +115 | +8% |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $2.9K | +$1.5K | +424 | +79% |
|
5
CIBC Private Wealth Group
Atlanta,
Georgia
| $1.09K | – | – | – |
|
6
BlackRock
New York
| $904 | – | – | – |
|
7
Morgan Stanley
New York
| $784 | – | – | – |
|
|
8
Bank of America
Charlotte,
North Carolina
| $48 | +$57 | +16 | New |
|
|
AF
9
Allworth Financial
Folsom,
California
| $4 | – | – | – |
|
|
10
Fidelity Investments
Boston,
Massachusetts
| $3 | +$4 | +1 | New |
|
|
11
Wells Fargo
San Francisco,
California
| – | -$8 | -2 | Closed |
|
|
TAM
12
Tucker Asset Management
Littleton,
Colorado
| – | -$4 | -1 | Closed |
|
13
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$4 | +1 | New |
|
TENX Hedge Fund Activity: Q2 2024 in Review
11 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q2 2024, worth a combined $57.2K — up 87% from $30.5K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new TENX positions and 2 closed out — a net gain of 2 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $39.1K. The largest seller was Wells Fargo, exiting entirely with an estimated $8 sold.
- 11 institutional investors held Tenax Therapeutics (TENX) as of Q2 2024, up from 9 in Q1 2024.
- Funds reported $57.2K of Tenax Therapeutics stock for Q2 2024, up 87% quarter-over-quarter.
- 4 funds opened new Tenax Therapeutics positions in Q2 2024 and 2 closed out, a net change of +2 holders.
- The largest Tenax Therapeutics buyer in Q2 2024 was Geode Capital Management, an estimated $39.1K added.
- The largest Tenax Therapeutics seller in Q2 2024 was Wells Fargo, an estimated $8 sold.
Based on aggregated 13F filings for Q2 2024.